ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Molecular Biomarkers Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-19S6143
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Molecular Biomarkers Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cancer Molecular Biomarkers Market Research Report 2025

Code: QYRE-Auto-19S6143
Report
August 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Correlogic Systems
AgendiaBv
Biomerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix Inc
Clarient
Biomoda
Beckman Coulter
Dickinson

Cancer Molecular Biomarkers Market

The global market for Cancer Molecular Biomarkers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments.
Factors such as technological advancements, increasing research and development activities, increase in funding from various government and non-government organizations, rise in healthcare expenditure, non invasive technology, increasing incidences of cancer, and streamlined drug delivery process are expected to drive the market for cancer molecular biomarkers .In addition, growing survival rates and increased accuracy of diagnosis with the help of biomarkers are expected to drive market for cancer molecular biomarkers.
This report aims to provide a comprehensive presentation of the global market for Cancer Molecular Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Molecular Biomarkers.
The Cancer Molecular Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Molecular Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Molecular Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Molecular Biomarkers Market Report

Report Metric Details
Report Name Cancer Molecular Biomarkers Market
Segment by Type
  • Genetic Methods
  • Protein Methods
  • Imaging
Segment by Application
  • Pharmaceutical
  • Medical Laboratory
  • Hospital
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Correlogic Systems, AgendiaBv, BioMerieux, Aureon Laboratories, Astellas Pharma US, Becton, Diadexus, Abbott Laboratories, Affymetrix, Clarient, Biomoda, Beckman Coulter, Dickinson
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Molecular Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Molecular Biomarkers Market report?

Ans: The main players in the Cancer Molecular Biomarkers Market are Correlogic Systems, AgendiaBv, BioMerieux, Aureon Laboratories, Astellas Pharma US, Becton, Diadexus, Abbott Laboratories, Affymetrix, Clarient, Biomoda, Beckman Coulter, Dickinson

What are the Application segmentation covered in the Cancer Molecular Biomarkers Market report?

Ans: The Applications covered in the Cancer Molecular Biomarkers Market report are Pharmaceutical, Medical Laboratory, Hospital

What are the Type segmentation covered in the Cancer Molecular Biomarkers Market report?

Ans: The Types covered in the Cancer Molecular Biomarkers Market report are Genetic Methods, Protein Methods, Imaging

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Molecular Biomarkers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Methods
1.2.3 Protein Methods
1.2.4 Imaging
1.3 Market by Application
1.3.1 Global Cancer Molecular Biomarkers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Medical Laboratory
1.3.4 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Molecular Biomarkers Market Perspective (2020-2031)
2.2 Global Cancer Molecular Biomarkers Growth Trends by Region
2.2.1 Global Cancer Molecular Biomarkers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Molecular Biomarkers Historic Market Size by Region (2020-2025)
2.2.3 Cancer Molecular Biomarkers Forecasted Market Size by Region (2026-2031)
2.3 Cancer Molecular Biomarkers Market Dynamics
2.3.1 Cancer Molecular Biomarkers Industry Trends
2.3.2 Cancer Molecular Biomarkers Market Drivers
2.3.3 Cancer Molecular Biomarkers Market Challenges
2.3.4 Cancer Molecular Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Molecular Biomarkers Players by Revenue
3.1.1 Global Top Cancer Molecular Biomarkers Players by Revenue (2020-2025)
3.1.2 Global Cancer Molecular Biomarkers Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Molecular Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Molecular Biomarkers Revenue
3.4 Global Cancer Molecular Biomarkers Market Concentration Ratio
3.4.1 Global Cancer Molecular Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Molecular Biomarkers Revenue in 2024
3.5 Global Key Players of Cancer Molecular Biomarkers Head office and Area Served
3.6 Global Key Players of Cancer Molecular Biomarkers, Product and Application
3.7 Global Key Players of Cancer Molecular Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Molecular Biomarkers Breakdown Data by Type
4.1 Global Cancer Molecular Biomarkers Historic Market Size by Type (2020-2025)
4.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2026-2031)
5 Cancer Molecular Biomarkers Breakdown Data by Application
5.1 Global Cancer Molecular Biomarkers Historic Market Size by Application (2020-2025)
5.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Molecular Biomarkers Market Size (2020-2031)
6.2 North America Cancer Molecular Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Molecular Biomarkers Market Size by Country (2020-2025)
6.4 North America Cancer Molecular Biomarkers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Molecular Biomarkers Market Size (2020-2031)
7.2 Europe Cancer Molecular Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Molecular Biomarkers Market Size by Country (2020-2025)
7.4 Europe Cancer Molecular Biomarkers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Molecular Biomarkers Market Size (2020-2031)
8.2 Asia-Pacific Cancer Molecular Biomarkers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Molecular Biomarkers Market Size (2020-2031)
9.2 Latin America Cancer Molecular Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Molecular Biomarkers Market Size by Country (2020-2025)
9.4 Latin America Cancer Molecular Biomarkers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Molecular Biomarkers Market Size (2020-2031)
10.2 Middle East & Africa Cancer Molecular Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Correlogic Systems
11.1.1 Correlogic Systems Company Details
11.1.2 Correlogic Systems Business Overview
11.1.3 Correlogic Systems Cancer Molecular Biomarkers Introduction
11.1.4 Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.1.5 Correlogic Systems Recent Development
11.2 AgendiaBv
11.2.1 AgendiaBv Company Details
11.2.2 AgendiaBv Business Overview
11.2.3 AgendiaBv Cancer Molecular Biomarkers Introduction
11.2.4 AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.2.5 AgendiaBv Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Cancer Molecular Biomarkers Introduction
11.3.4 BioMerieux Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.3.5 BioMerieux Recent Development
11.4 Aureon Laboratories
11.4.1 Aureon Laboratories Company Details
11.4.2 Aureon Laboratories Business Overview
11.4.3 Aureon Laboratories Cancer Molecular Biomarkers Introduction
11.4.4 Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.4.5 Aureon Laboratories Recent Development
11.5 Astellas Pharma US
11.5.1 Astellas Pharma US Company Details
11.5.2 Astellas Pharma US Business Overview
11.5.3 Astellas Pharma US Cancer Molecular Biomarkers Introduction
11.5.4 Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.5.5 Astellas Pharma US Recent Development
11.6 Becton
11.6.1 Becton Company Details
11.6.2 Becton Business Overview
11.6.3 Becton Cancer Molecular Biomarkers Introduction
11.6.4 Becton Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.6.5 Becton Recent Development
11.7 Diadexus
11.7.1 Diadexus Company Details
11.7.2 Diadexus Business Overview
11.7.3 Diadexus Cancer Molecular Biomarkers Introduction
11.7.4 Diadexus Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.7.5 Diadexus Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Cancer Molecular Biomarkers Introduction
11.8.4 Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.8.5 Abbott Laboratories Recent Development
11.9 Affymetrix
11.9.1 Affymetrix Company Details
11.9.2 Affymetrix Business Overview
11.9.3 Affymetrix Cancer Molecular Biomarkers Introduction
11.9.4 Affymetrix Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.9.5 Affymetrix Recent Development
11.10 Clarient
11.10.1 Clarient Company Details
11.10.2 Clarient Business Overview
11.10.3 Clarient Cancer Molecular Biomarkers Introduction
11.10.4 Clarient Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.10.5 Clarient Recent Development
11.11 Biomoda
11.11.1 Biomoda Company Details
11.11.2 Biomoda Business Overview
11.11.3 Biomoda Cancer Molecular Biomarkers Introduction
11.11.4 Biomoda Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.11.5 Biomoda Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Details
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Cancer Molecular Biomarkers Introduction
11.12.4 Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.12.5 Beckman Coulter Recent Development
11.13 Dickinson
11.13.1 Dickinson Company Details
11.13.2 Dickinson Business Overview
11.13.3 Dickinson Cancer Molecular Biomarkers Introduction
11.13.4 Dickinson Revenue in Cancer Molecular Biomarkers Business (2020-2025)
11.13.5 Dickinson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Correlogic Systems
AgendiaBv
Biomerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix Inc
Clarient
Biomoda
Beckman Coulter
Dickinson
List of Tables
 Table 1. Global Cancer Molecular Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Genetic Methods
 Table 3. Key Players of Protein Methods
 Table 4. Key Players of Imaging
 Table 5. Global Cancer Molecular Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cancer Molecular Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cancer Molecular Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cancer Molecular Biomarkers Market Share by Region (2020-2025)
 Table 9. Global Cancer Molecular Biomarkers Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cancer Molecular Biomarkers Market Share by Region (2026-2031)
 Table 11. Cancer Molecular Biomarkers Market Trends
 Table 12. Cancer Molecular Biomarkers Market Drivers
 Table 13. Cancer Molecular Biomarkers Market Challenges
 Table 14. Cancer Molecular Biomarkers Market Restraints
 Table 15. Global Cancer Molecular Biomarkers Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cancer Molecular Biomarkers Market Share by Players (2020-2025)
 Table 17. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Molecular Biomarkers as of 2024)
 Table 18. Ranking of Global Top Cancer Molecular Biomarkers Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cancer Molecular Biomarkers Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cancer Molecular Biomarkers, Headquarters and Area Served
 Table 21. Global Key Players of Cancer Molecular Biomarkers, Product and Application
 Table 22. Global Key Players of Cancer Molecular Biomarkers, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cancer Molecular Biomarkers Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2020-2025)
 Table 26. Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2026-2031)
 Table 28. Global Cancer Molecular Biomarkers Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cancer Molecular Biomarkers Revenue Market Share by Application (2020-2025)
 Table 30. Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cancer Molecular Biomarkers Revenue Market Share by Application (2026-2031)
 Table 32. North America Cancer Molecular Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cancer Molecular Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cancer Molecular Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cancer Molecular Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cancer Molecular Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cancer Molecular Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cancer Molecular Biomarkers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cancer Molecular Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cancer Molecular Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cancer Molecular Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cancer Molecular Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Correlogic Systems Company Details
 Table 48. Correlogic Systems Business Overview
 Table 49. Correlogic Systems Cancer Molecular Biomarkers Product
 Table 50. Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 51. Correlogic Systems Recent Development
 Table 52. AgendiaBv Company Details
 Table 53. AgendiaBv Business Overview
 Table 54. AgendiaBv Cancer Molecular Biomarkers Product
 Table 55. AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 56. AgendiaBv Recent Development
 Table 57. BioMerieux Company Details
 Table 58. BioMerieux Business Overview
 Table 59. BioMerieux Cancer Molecular Biomarkers Product
 Table 60. BioMerieux Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 61. BioMerieux Recent Development
 Table 62. Aureon Laboratories Company Details
 Table 63. Aureon Laboratories Business Overview
 Table 64. Aureon Laboratories Cancer Molecular Biomarkers Product
 Table 65. Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 66. Aureon Laboratories Recent Development
 Table 67. Astellas Pharma US Company Details
 Table 68. Astellas Pharma US Business Overview
 Table 69. Astellas Pharma US Cancer Molecular Biomarkers Product
 Table 70. Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 71. Astellas Pharma US Recent Development
 Table 72. Becton Company Details
 Table 73. Becton Business Overview
 Table 74. Becton Cancer Molecular Biomarkers Product
 Table 75. Becton Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 76. Becton Recent Development
 Table 77. Diadexus Company Details
 Table 78. Diadexus Business Overview
 Table 79. Diadexus Cancer Molecular Biomarkers Product
 Table 80. Diadexus Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 81. Diadexus Recent Development
 Table 82. Abbott Laboratories Company Details
 Table 83. Abbott Laboratories Business Overview
 Table 84. Abbott Laboratories Cancer Molecular Biomarkers Product
 Table 85. Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 86. Abbott Laboratories Recent Development
 Table 87. Affymetrix Company Details
 Table 88. Affymetrix Business Overview
 Table 89. Affymetrix Cancer Molecular Biomarkers Product
 Table 90. Affymetrix Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 91. Affymetrix Recent Development
 Table 92. Clarient Company Details
 Table 93. Clarient Business Overview
 Table 94. Clarient Cancer Molecular Biomarkers Product
 Table 95. Clarient Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 96. Clarient Recent Development
 Table 97. Biomoda Company Details
 Table 98. Biomoda Business Overview
 Table 99. Biomoda Cancer Molecular Biomarkers Product
 Table 100. Biomoda Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 101. Biomoda Recent Development
 Table 102. Beckman Coulter Company Details
 Table 103. Beckman Coulter Business Overview
 Table 104. Beckman Coulter Cancer Molecular Biomarkers Product
 Table 105. Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 106. Beckman Coulter Recent Development
 Table 107. Dickinson Company Details
 Table 108. Dickinson Business Overview
 Table 109. Dickinson Cancer Molecular Biomarkers Product
 Table 110. Dickinson Revenue in Cancer Molecular Biomarkers Business (2020-2025) & (US$ Million)
 Table 111. Dickinson Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Cancer Molecular Biomarkers Picture
 Figure 2. Global Cancer Molecular Biomarkers Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Molecular Biomarkers Market Share by Type: 2024 VS 2031
 Figure 4. Genetic Methods Features
 Figure 5. Protein Methods Features
 Figure 6. Imaging Features
 Figure 7. Global Cancer Molecular Biomarkers Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cancer Molecular Biomarkers Market Share by Application: 2024 VS 2031
 Figure 9. Pharmaceutical Case Studies
 Figure 10. Medical Laboratory Case Studies
 Figure 11. Hospital Case Studies
 Figure 12. Cancer Molecular Biomarkers Report Years Considered
 Figure 13. Global Cancer Molecular Biomarkers Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cancer Molecular Biomarkers Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cancer Molecular Biomarkers Market Share by Region: 2024 VS 2031
 Figure 16. Global Cancer Molecular Biomarkers Market Share by Players in 2024
 Figure 17. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Molecular Biomarkers as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cancer Molecular Biomarkers Revenue in 2024
 Figure 19. North America Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cancer Molecular Biomarkers Market Share by Country (2020-2031)
 Figure 21. United States Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cancer Molecular Biomarkers Market Share by Country (2020-2031)
 Figure 25. Germany Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cancer Molecular Biomarkers Market Share by Region (2020-2031)
 Figure 33. China Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cancer Molecular Biomarkers Market Share by Country (2020-2031)
 Figure 41. Mexico Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cancer Molecular Biomarkers Market Share by Country (2020-2031)
 Figure 45. Turkey Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cancer Molecular Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Correlogic Systems Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 49. AgendiaBv Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 50. BioMerieux Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 51. Aureon Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 52. Astellas Pharma US Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 53. Becton Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 54. Diadexus Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 55. Abbott Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 56. Affymetrix Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 57. Clarient Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 58. Biomoda Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 59. Beckman Coulter Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 60. Dickinson Revenue Growth Rate in Cancer Molecular Biomarkers Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Cancer Biomarker Market Insights Forecast to 2030
Global Oncology Biomarker Market Insights Forecast to 2030
Global Molecular Diagnostics Cancer Market Insights Forecast to 2030
Global Commercializing Biomarkers Market Research Report 2025
Global Cancer Biomarkers Detection Market Research Report 2024
Global Noninvasive Cancer Biomarkers Market Research Report 2024
Global Biomarker Testing for Cancer Market Research Report 2024
Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024
Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024
Global Biomarker Market Research Report 2024
Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clinical Biomarker Testing Market Research Report 2024
Global Clinical Biomarkers Market Research Report 2024
Global Viral Molecular Diagnostics Market Research Report 2024
Global Oncology Based Molecular Diagnostics Market Insights Forecast to 2030
Global Molecular Oncology Market Research Report 2024
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030
Global Breast Cancer Molecular Diagnostics Market Research Report 2024
Global Tumor Marker Test Kits Market Research Report 2025
Global Brain Cancer Molecular Diagnostics Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions